Here at the Janssen Health Policy Centre
our mission is to raise awareness on issues impacting healthcare policy, build
consensus through dialogue, and shape recommendations for future policies

Report-15/11/2016
Tackling Tuberculosis In South Africa

As a relatively wealthy African country and one of the BRICS nations (Brazil, Russia, India, China and South Africa), South Africa has been able to make more substantial investments in combating tuberculosis (TB) and multi-drug-resistant tuberculosis (MDR TB) than many others in the region. This, combined with strong political will, has put South Africa ahead of many of its peers in the fight against the disease.

download
Report-09/11/2016
Tackling Tuberculosis in Kenya

With the help of international funding from the Global Fund to Fight AIDS, Tuberculosis and Malaria, the United States Agency for International Development (USAID) and others, Kenya is planning to scale up its response to tuberculosis (TB) and multidrug-resistant tuberculosis (MDR TB) by 2017.1 But although the political will to fight the disease is there, experts and policymakers recognise that MDR TB cannot be tackled in isolation.

download
Report-09/11/2016
Tackling Tuberculosis in Nigeria

For Nigeria, the barriers to tackling multidrug-resistant tuberculosis (MDR TB) include external factors such as the Boko Haram insurgency (which is also hampering the battle against polio). However, persistent weaknesses in the country’s health system that are lowering its diagnosis and treatment capacity are also contributing to Nigeria’s struggle to control tuberculosis (TB) and MDR TB.

download
Report-31/10/2016
Tackling Tuberculosis in Ethiopia

Although Ethiopia has only limited resources to spend on combating tuberculosis (TB) and multidrug-resistant tuberculosis (MDR TB), its innovative, community-based approach demonstrates that a poor country which lacks sophisticated healthcare systems and medical specialists can nevertheless respond aggressively in the battle against TB and MDR TB. The country certainly faces challenges. It ranks ninth in the world in terms of its TB burden— tuberculosis remains one of the leading causes of mortality in Ethiopia—and it is one of the 27 MDR TB high-burden countries. Meanwhile, 2.3% of new TB cases and 17.8% of previously treated TB cases are estimated to have MDR.

download
Report-28/10/2016
Tackling Tuberculosis: Recent progress and challenges

As countries strive to reach the UN Sustainable Development Goals for 2030, tuberculosis (TB) continues to challenge policymakers around the globe, with developing countries bearing a particularly onerous burden.

download
Report-15/12/2014
Ancient enemy, modern imperative: A time for greater action against tuberculosis

An Economist Intelligence Unit report, supported by Janssen, which calls attention to the key changes that need to take place to improve success against tuberculosis.

download
Report-01/10/2014
The fight against tuberculosis

On the occasion of a multi-stakeholder policy debate in Brussels on 24 March 2014 organised by European Voice and supported by Janssen, a special report “The fight against tuberculosis” was published. The report provides an insight into the challenges for policy makers in Europe. The event, “Multi-drug-resistant tuberculosis: how is Europe responding to the new challenge?” was supported by 11 partnering organisations (including Janssen). “This document is not authored by Janssen, and was made possible through an unconditional sponsorship from Janssen whereby the authors had full editorial input and control. This document reflects the opinions and views of the authors, and are not necessarily those of Janssen.”

download
Report-10/09/2014
FT Health Combating Tuberculosis

Although Tuberculosis (TB) is a curable and preventable disease, 1.3 million people died of the infection in 2012. In the same year, an estimated 450 000 people developed Multidrug-Resistant TB and there were an estimated 170 000 deaths from Multidrug-Resistant TB. An FT special report, published on 24 March 2014, gives a global overview of the threat tuberculosis still poses for public health worldwide. “This document is not authored by Janssen, and was made possible through an unconditional sponsorship from Janssen whereby the authors had full editorial input and control. This document reflects the opinions and views of the authors, and are not necessarily those of Janssen.”

download

The fight against tuberculosis

On the occasion of a multi-stakeholder policy debate in Brussels on 24 March 2014 organised by European Voice and supported by Janssen, a special report “The fight against tuberculosis” was published. The report provides an insight into the challenges for policy makers in Europe. The event, “Multi-drug-resistant tuberculosis: how is Europe responding to the new challenge?” was supported by 11 partnering organisations (including Janssen).

“This document is not authored by Janssen, and was made possible through an unconditional sponsorship from Janssen whereby the authors had full editorial input and control. This document reflects the opinions and views of the authors, and are not necessarily those of Janssen.”

Download The fight against tuberculosis

“This document is not authored by Janssen, and was made possible through an unconditional sponsorship from Janssen whereby the authors had full editorial input and control. This document reflects the opinions and views of the authors, and are not necessarily those of Janssen.”

Download the report

Ancient enemy, modern imperative: A time for greater action against tuberculosis

Ancient enemy, modern imperative: A time for greater action against tuberculosis is an Economist Intelligence Unit report, supported by Janssen, which calls attention to the key changes that need to take place to improve success against tuberculosis. The report highlights the evolving tuberculosis crisis and emphasises the urgent need for integrated care, harnessing innovative yet cost-effective strategies and raising tuberculosis on national and global agendas to overcome this highly infectious, yet treatable killer.

Download the report

Baltics report (English web version)
Romania report (English web version)
Poland report (English web version)

Download infographic

Watch the video

FT Health Combating Tuberculosis

Although Tuberculosis (TB) is a curable and preventable disease, 1.3 million people died of the infection in 2012. In the same year, an estimated 450 000 people developed Multidrug-Resistant TB and there were an estimated 170 000 deaths from Multidrug-Resistant TB. An FT special report, published on 24 March 2014, gives a global overview of the threat tuberculosis still poses for public health worldwide.

Download FT Health Combating Tuberculosis special report

“This document is not authored by Janssen, and was made possible through an unconditional sponsorship from Janssen whereby the authors had full editorial input and control. This document reflects the opinions and views of the authors, and are not necessarily those of Janssen.”

Download the report

Tackling Tuberculosis In South Africa: Building On The Political Momentum

This South African case study, written by the Economist Intelligence Unit (EIU) and supported by Janssen, examines the local state of TB including national policy and progress in the areas of prevention, diagnosis and treatment. It features interviews with the following TB experts;

  • Mario Raviglione, director of the Global TB Programme at the World Health Organisation (WHO)
  • David Mametja, chief director of TB control at South Africa’s Department of Health
  • Keertan Dheda, head of pulmonology at Groote Schuur Hospital, University of Cape Town
  • Eliud Wandwalo, senior disease co-ordinator for TB at the Global Fund
  • Norbert Ndjeka, director of drug-resistant TB, TB and HIV at South Africa’s Department of Health

This case study has been developed in an effort to ensure tuberculosis remains front of mind for policy stakeholders and to keep up momentum as we all work towards the United Nations Sustainable Development Goal – to eradicate TB by 2030.

The EIU will be publishing this case study along with 3 other case studies looking at Ethiopia, Nigeria and Kenya, and a global article (which provides an update to the EIU’s 2014 report, Ancient enemy, modern imperative: A time for greater action against tuberculosis) on Wednesday 26th October 2016. The articles will be made available on the EIU website. We would be grateful if you could please not share these articles until they have been published online.

Download the report

 

Tackling Tuberculosis in Nigeria: Funding Gaps And Fragmentation

This Nigerian case study, written by the Economist Intelligence Unit (EIU) and supported by Janssen, examines the local state of TB including national policy and progress in the areas of prevention, diagnosis and treatment. It features interviews with the following TB experts;

  • Mario Raviglione, director of the Global TB Programme at the World Health Organisation (WHO)
  • Eliud Wandwalo, senior disease co-ordinator for TB at the Global Fund
  • Professor Lovett Lawson, chairman of the board of the Nigeria Stop TB Partnership

This case study has been developed in an effort to ensure tuberculosis remains front of mind for policy stakeholders and to keep up momentum as we all work towards the United Nations Sustainable Development Goal – to eradicate TB by 2030.

The EIU will be publishing this case study along with 3 other case studies looking at Ethiopia, South Africa and Kenya, and a global article (which provides an update to the EIU’s 2014 report, Ancient enemy, modern imperative: A time for greater action against tuberculosis) on Wednesday 26th October 2016. The articles will be made available on the EIU website. We would be grateful if you could please not share these articles until they have been published online.

Download the report

 

Tackling Tuberculosis in Kenya: A Decentralised Approach To Care

This Kenyan case study, written by the Economist Intelligence Unit (EIU) and supported by Janssen, examines the local state of TB including national policy and progress in the areas of prevention, diagnosis and treatment. It features interviews with the following TB experts;

  • Evaline Kibuchi, chief national co-ordinator at the Stop TB Partnership-Kenya
  • Joseph Sitienei, head of the Division of National Strategic Public Health Programmes at the Kenyan Ministry of Health
  • Eliud Wandwalo, senior disease co-ordinator for tuberculosis at the Global Fund

This case study has been developed in an effort to ensure tuberculosis remains front of mind for policy stakeholders and to keep up momentum as we all work towards the United Nations Sustainable Development Goal – to eradicate TB by 2030.

The EIU will be publishing this case study along with 3 other case studies looking at Nigeria, South Africa and Ethiopia, and a global article (which provides an update to the EIU’s 2014 report, Ancient enemy, modern imperative: A time for greater action against tuberculosis) on Wednesday 26th October 2016. The articles will be made available on the EIU website. We would be grateful if you could please not share these articles until they have been published online.

Download the report

 

Tackling Tuberculosis in Ethiopia: A Community-Based Approach

This Ethiopian case study article, written by the Economist Intelligence Unit (EIU) and supported by Janssen, examines the local state of TB including national policy and progress in the areas of prevention, diagnosis and treatment. It features interviews with the following TB experts;

  • Daniel Datiko, executive director of REACH Ethiopia
  • Mario Raviglione, director of the Global TB Programme at the World Health Organisation (WHO).

This case study has been developed in an effort to ensure tuberculosis remains front of mind for policy stakeholders and to keep up momentum as we all work towards the United Nations Sustainable Development Goal – to eradicate TB by 2030.

The EIU will be publishing this case study along with 3 other case studies looking at Nigeria, South Africa and Kenya, and a global article (which provides an update to the EIU’s 2014 report, Ancient enemy, modern imperative: A time for greater action against tuberculosis) on Wednesday 26th October 2016. The articles will be made available on the EIU website. We would be grateful if you could please not share these articles until they have been published online.

Download the report.

 

Tackling Tuberculosis: Recent progress and challenges

As countries strive to reach the UN Sustainable Development Goals for 2030, tuberculosis (TB) continues to challenge policymakers around the globe, with developing countries bearing a particularly onerous burden.

Although TB was responsible for around 1.5m deaths in 2014, down from nearly 1.8m in 1990, it is now the leading infectious disease killer worldwide, surpassing HIV/AIDS.1 According to Mario Raviglione, director of the Global TB Programme at the World Health Organisation (WHO), incidence of the disease has been falling by around 1.5% annually for around a decade, but meeting the WHO’s goal of reducing TB by 90% by 2030 would require a reduction in incidence of 10% per year over the next decade—a goal that looks increasingly precarious, especially with an estimated 3m cases going unreported.

In its 2014 report Ancient enemy, modern imperative: A time for greater action against tuberculosis The Economist Intelligence Unit (EIU) identified a number of factors that were undermining efforts to tackle the disease, including a slow, insufficiently ambitious and frequently ineffective response; the increasing public-health crisis of multidrugresistant tuberculosis (MDR TB), highlighting the failings of existing efforts; a high level of stigma faced by patients; and overly provider-centred efforts.2

Although there is an increasing awareness of the particular burden posed by MDR TB, it is nevertheless expected to account for around one-quarter of the 10m annual deaths likely to be associated with drug resistance by 2050, according to the final 2016 Review on Antimicrobial Resistance, commissioned by the UK Government in collaboration with the Wellcome Trust.3 Improving diagnostic and treatment regimens for MDR TB remains a key challenge. In addition, the experts interviewed for this report say that closer links between TB and HIV programmes could help to identify those in need of treatment.

This update report will assess the progress made in the global response to TB since The EIU’s 2014 study. We will first consider the socioeconomic and political context of tackling TB and then look at policy and progress in the areas of prevention, diagnosis and treatment.

Download the report

  • Fight Against Neglected Tropical Diseases
    Fight Against Neglected Tropical Diseases

Report archive